Mesothelioma (HBME-1) Antibody

 Mesothelioma (HBME-1) Antibody

Sensitive Marker for Mesothelial and Thyroid Carcinomas

The Mesothelioma (HBME-1) antibody, developed by Talent Biomedical, is a high-quality immunohistochemistry (IHC) reagent used for detecting the Hector Battifora Mesothelial-1 (HBME-1) antigen in mesothelial and epithelial cells.
HBME-1 is a membrane-associated glycoprotein expressed in mesothelial cells and certain epithelial malignancies, making it an essential marker in distinguishing malignant mesothelioma from other benign and malignant epithelial lesions, especially in the thyroid and lung.

In IHC staining, HBME-1 antibody exhibits membranous and/or cytoplasmic brown staining in positive cells, supporting accurate differentiation between papillary and follicular thyroid carcinomas and benign thyroid nodules.

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co. is the exclusive representative of Talent Biomedical Technology Co., Ltd. (China) in Iran and the official distributor of professional IHC diagnostic antibodies, including HBME-1 (Mesothelioma Antibody).
With a focus on diagnostic precision, international standards, and product reliability,
Fardad Azma Rad provides cutting-edge immunohistochemistry reagents to pathology laboratories and cancer diagnostic centers across Iran.

🔬 Features and Benefits

• Specific marker for mesothelial cells and thyroid carcinomas

• Distinguishes malignant mesothelioma from other epithelial neoplasms

• Produces membranous or cytoplasmic brown staining with high clarity

• Fully compatible with FFPE tissue sections and DAB detection systems

• Certified CE-IVD and manufactured under stringent quality control procedures

💡 Diagnostic Applications

• Detection of Malignant Mesothelioma

• Differentiation of papillary and follicular thyroid carcinomas from benign lesions

• Identification of mesothelial tumors in pleural and peritoneal tissues

• Research on HBME-1 expression and membrane-associated tumor markers

“Download Brochure”